The NHS in the Black Country is now offering the Respiratory Syncytial Virus (RSV) vaccine at selected local pharmacies, making it easier than ever for eligible groups to get protected.

The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.